ArticlePharmaceuticals (Basel, Switzerland)2020

Vascular α1A Adrenergic Receptors as a Potential Therapeutic Target for IPAD in Alzheimer's Disease.

Miles Frost et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.